LAURUSLABS.BO

Laurus Labs Ltd · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$7.43B

PE Ratio

84.96

EV to Ebitda

—

Earnings Yield

1.00%

Revenue (TTM)

$712.9M

Net Income (TTM)

$87.5M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

6.00%

Profit Margin

13.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core6 fields›

Market Cap$7.43B

Revenue TTM$712.9M

Shares Outstanding539.9M

Float353938972

Insider Ownership32.00%

Institutional Ownership29.00%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)6.00%

Rev Growth Est 1Y Forward0.14

EPS Growth (Quarterly YoY)19.00%

EPS Growth Est Quarterly3.68

LT EPS Growth Estimates18.00%

Operations16 fields›

Revenue TTM$712.9M

Gross Margin TTM61.00%

Gross Margin (Quarterly)61.00%

Operating Margin TTM22.00%

Operating Margin (Quarterly)20.00%

Operating Expenses TTM$21.2M

Profit Margin TTM13.00%

Profit Margin (Quarterly)14.00%

Net Income TTM$87.5M

EPS TTM15.63

EPS (Quarterly)4.66

EBITDA Margin TTM27.00%

EBITDA TTM$190.2M

Capex % of Revenue TTM16.00%

Capital Expenditures$117.3M

FCF % of Revenue (Quarterly)-1.00%

Efficiency1 fields›

ROA9.00%

Valuation7 fields›

P/E (TTM)84.96

P/E Forward0

EV/Revenues (TTM)10.26

Price To Book14.91

Price to Tangible Book15.78

Earnings Yield1.00%

Payout Ratio12.00%

Liquidity9 fields›

Cash Per Share1.85

Current Ratio1.22

Cash & ST Assets$633.8M

Goodwill & Intangibles$2640.30T

Total Assets$977.3M

Total Liabilities$1.95B

Shareholders Equity$498.8M

Interest Expense$21.2M

Goodwill % of Assets2804280.00%

Yields3 fields›

Payout Ratio12.00%

Earnings Yield1.00%

Buyback Yield0.00%